<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:DRMA="http://dermatarx.com/20260331"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="drma-20260331.xsd" xlink:type="simple"/>
    <context id="From2026-01-01to2026-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001853816</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_CommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001853816</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DRMA:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_WarrantsExercisableForOneShareOfCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001853816</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DRMA:WarrantsExercisableForOneShareOfCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001853816</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001853816</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001853816</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_StockCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001853816</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_StockCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001853816</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:DocumentType contextRef="From2026-01-01to2026-03-31" id="Fact000012">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2026-01-01to2026-03-31" id="Fact000013">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2026-01-01to2026-03-31" id="Fact000014">DERMATA THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2026-01-01to2026-03-31" id="Fact000015">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2026-01-01to2026-03-31" id="Fact000016">001-40739</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2026-01-01to2026-03-31" id="Fact000017">86-3218736</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2026-01-01to2026-03-31" id="Fact000018">3525     Del Mar Heights Rd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2026-01-01to2026-03-31" id="Fact000019">#322</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2026-01-01to2026-03-31" id="Fact000020">San     Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2026-01-01to2026-03-31" id="Fact000021">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2026-01-01to2026-03-31" id="Fact000022">92130</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2026-01-01to2026-03-31" id="Fact000023">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2026-01-01to2026-03-31" id="Fact000024">800-2543</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2026-01-01to2026-03-31" id="Fact000025">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2026-01-01to2026-03-31" id="Fact000026">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2026-01-01to2026-03-31" id="Fact000027">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2026-01-01to2026-03-31" id="Fact000028">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2026-01-012026-03-31_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000029">Common Stock, par value     $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-01-012026-03-31_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000030">DRMA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-01-012026-03-31_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000031">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2026-01-012026-03-31_custom_WarrantsExercisableForOneShareOfCommonStockMember"
      id="Fact000032">Warrants, exercisable for     one share of Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-01-012026-03-31_custom_WarrantsExercisableForOneShareOfCommonStockMember"
      id="Fact000033">DRMAW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-01-012026-03-31_custom_WarrantsExercisableForOneShareOfCommonStockMember"
      id="Fact000034">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2026-01-01to2026-03-31" id="Fact000035">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2026-01-01to2026-03-31" id="Fact000036">true</dei:EntityExTransitionPeriod>
    <dei:AmendmentFlag contextRef="From2026-01-01to2026-03-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2026-01-01to2026-03-31" id="Fact000004">0001853816</dei:EntityCentralIndexKey>
    <us-gaap:InventoryNet
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0048"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2026-03-31"
      decimals="-3"
      id="Fact000041"
      unitRef="USD">6945000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000042"
      unitRef="USD">7522000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2026-03-31"
      decimals="-3"
      id="Fact000044"
      unitRef="USD">427000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000045"
      unitRef="USD">342000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:InventoryNet
      contextRef="AsOf2026-03-31"
      decimals="-3"
      id="Fact000047"
      unitRef="USD">93000</us-gaap:InventoryNet>
    <us-gaap:Assets
      contextRef="AsOf2026-03-31"
      decimals="-3"
      id="Fact000050"
      unitRef="USD">7465000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000051"
      unitRef="USD">7864000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2026-03-31"
      decimals="-3"
      id="Fact000056"
      unitRef="USD">318000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000057"
      unitRef="USD">461000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2026-03-31"
      decimals="-3"
      id="Fact000059"
      unitRef="USD">734000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000060"
      unitRef="USD">1180000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2026-03-31"
      decimals="-3"
      id="Fact000062"
      unitRef="USD">1052000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000063"
      unitRef="USD">1641000</us-gaap:Liabilities>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31"
      decimals="-3"
      id="Fact000065"
      unitRef="USD">6413000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000066"
      unitRef="USD">6223000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2026-03-31"
      decimals="-3"
      id="Fact000068"
      unitRef="USD">7465000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000069"
      unitRef="USD">7864000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2026-01-01to2026-03-31"
      decimals="-3"
      id="Fact000074"
      unitRef="USD">384000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-012025-03-31"
      decimals="-3"
      id="Fact000075"
      unitRef="USD">1281000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2026-01-01to2026-03-31"
      decimals="-3"
      id="Fact000077"
      unitRef="USD">1542000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2025-01-012025-03-31"
      decimals="-3"
      id="Fact000078"
      unitRef="USD">1058000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2026-01-01to2026-03-31"
      decimals="-3"
      id="Fact000080"
      unitRef="USD">1926000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2025-01-012025-03-31"
      decimals="-3"
      id="Fact000081"
      unitRef="USD">2339000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2026-01-01to2026-03-31"
      decimals="-3"
      id="Fact000083"
      unitRef="USD">-1926000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-01-012025-03-31"
      decimals="-3"
      id="Fact000084"
      unitRef="USD">-2339000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2026-01-01to2026-03-31"
      decimals="-3"
      id="Fact000086"
      unitRef="USD">79000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2025-01-012025-03-31"
      decimals="-3"
      id="Fact000087"
      unitRef="USD">36000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2026-01-01to2026-03-31"
      decimals="-3"
      id="Fact000089"
      unitRef="USD">-1847000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-012025-03-31"
      decimals="-3"
      id="Fact000090"
      unitRef="USD">-2303000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact000092"
      unitRef="USDPShares">-0.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact000094"
      unitRef="USDPShares">-0.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact000096"
      unitRef="USDPShares">-4.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact000098"
      unitRef="USDPShares">-4.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact000100"
      unitRef="Shares">3858921</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact000102"
      unitRef="Shares">3858921</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact000104"
      unitRef="Shares">515465</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-01-012025-03-31"
      decimals="INF"
      id="Fact000106"
      unitRef="Shares">515465</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2026-01-012026-03-31_us-gaap_StockCompensationPlanMember"
      decimals="-3"
      id="Fact000108"
      unitRef="USD">14000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-012025-03-31_us-gaap_StockCompensationPlanMember"
      decimals="-3"
      id="Fact000109"
      unitRef="USD">8000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2026-01-012026-03-31_us-gaap_StockCompensationPlanMember"
      decimals="-3"
      id="Fact000111"
      unitRef="USD">29000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2025-01-012025-03-31_us-gaap_StockCompensationPlanMember"
      decimals="-3"
      id="Fact000112"
      unitRef="USD">29000</us-gaap:SellingGeneralAndAdministrativeExpense>
</xbrl>
